Detalhe da pesquisa
1.
Treating paediatric hepatitis C in the era of direct-acting antiviral agents.
Liver Int
; 41(6): 1189-1200, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33533543
2.
Dynamic capabilities and high-tech entrepreneurial ventures' performance in the aftermath of an environmental jolt.
Long Range Plann
; : 102026, 2020 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32836389
3.
The HepTestContest: a global innovation contest to identify approaches to hepatitis B and C testing.
BMC Infect Dis
; 17(Suppl 1): 701, 2017 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29143673
4.
ABT-450, ritonavir, ombitasvir, and dasabuvir achieves 97% and 100% sustained virologic response with or without ribavirin in treatment-experienced patients with HCV genotype 1b infection.
Gastroenterology
; 147(2): 359-365.e1, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24818763
5.
Current status of first-line therapy, anti-angiogenic therapy and its combinations of other agents for unresectable hepatocellular carcinoma.
World J Gastrointest Oncol
; 13(12): 2038-2049, 2021 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35070040
6.
ENTREPRENEURSHIP. Cash from the crowd.
Science
; 348(6240): 1201-2, 2015 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26068827